Recent 13F filings as of December 2025 show that 7 institutional investors hold a position in Gain Therapeutics, Inc. (NASDAQ:GANX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| JONES FINANCIAL COMPANIES LLLP | 30 Sep, 2025 | 676,822 | -66 | -0.01% | $1,211,511.00 |
| DME Capital Management, LP | 30 Sep, 2025 | 566,130 | 0 | 0.00% | $1,002,050.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 534,352 | 0 | 0.00% | $945,803.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 373,558 | 373,558 | 0.00% | $661,197.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 344,146 | 53,684 | 18.48% | $609,190.00 |
| Cambridge Investment Research Advisors, Inc. | 30 Sep, 2025 | 318,645 | 139,145 | 77.52% | $564.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 175,107 | -101,326 | -36.65% | $309,939.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 155,675 | 79,163 | 103.46% | $275,545.00 |
| UBS Group AG | 30 Sep, 2025 | 140,677 | 108,042 | 331.06% | $248,998.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 126,100 | 32,100 | 34.15% | $223,197.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 116,184 | 3,677 | 3.27% | $205,646.00 |
| STATE STREET CORP | 30 Sep, 2025 | 91,137 | 20,000 | 28.11% | $161,312.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 88,399 | -11,771 | -11.75% | $156,466.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 80,435 | 884 | 1.11% | $142,370.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 72,450 | 72,450 | 0.00% | $128,237.00 |
| Virtu Financial LLC | 30 Sep, 2025 | 54,008 | 30,207 | 126.91% | $96.00 |
| Kovitz Investment Group Partners, LLC | 30 Sep, 2025 | 47,578 | 0 | 0.00% | $84,213.00 |
| Squarepoint Ops LLC | 30 Sep, 2025 | 38,537 | 38,537 | 0.00% | $68,210.00 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 35,820 | 0 | 0.00% | $63,401.00 |
| BENEDICT FINANCIAL ADVISORS INC | 30 Sep, 2025 | 35,000 | 12,500 | 55.56% | $61,950.00 |